Myeloproliferative Neoplasms News

Dean Lee, MD, PhD, has been appointed director of the cellular therapy and cancer immunotherapy program for Nationwide Children’s Hospital’s division of hematology/oncology/bone marrow transplantation and its Center for Childhood Cancer and Blood Diseases.

Lenalidomide induced sustained red blood cell transfusion independence in patients with transfusion-dependent lower-risk myelodysplastic syndrome who were refractory to or ineligible for erythropoiesis-stimulating agents, according to the results of an international phase 3 randomized controlled trial.

Ipilimumab induced complete responses among patients with hematologic malignancies who relapsed following allogeneic hematopoietic stem cell transplantation, according to the results of a study published in The New England Journal of Medicine.

Memorial Sloan Kettering Cancer Center launched a new initiative designed to help teens and young adults with cancer.

Prophylactic treatment with low-dose corticosteroids accelerated platelet recovery and significantly decreased the prevalence of acute graft-versus-host disease among high-risk patients undergoing haploidentical hematopoietic stem cell transplantation, according to the results of an open-label, randomized control trial.

Cancer treatment centers in the United States spent $173 million on advertising in the year 2014, according to a research letter published in JAMA Internal Medicine.

In years past, I have avoided using my monthly editorial to provide a report from the ASCO Annual Meeting, partly because the content from the meeting is already expertly covered in detail in HemOnc Today.

ASH announced seven recipients of the 2016 ASH Research Training Award for Fellows, a yearlong program designed to encourage careers in academic hematology by providing protected research during training.

The FDA approved dronabinol oral solution for the treatment of patients with cancer who experience chemotherapy-induced nausea and vomiting, according to a press release from the agent’s manufacturer.

Short sleep duration and frequent snoring prior to cancer diagnosis may shorten OS among postmenopausal women with breast cancer.